Anne Marchalot

Anne Marchalot

Auto-generated profile, based on publicly available information

Anne Marchalot

Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2022 in Blood
Verified
Journal Article
Open access
PDF file
MHMarion Haas
Marion Haas
GCGersende Caron
Gersende Caron
FCFabrice Chatonnet
Fabrice Chatonnet
SMStéphane Manenti
Stéphane Manenti
EAElina Alaterre
Elina Alaterre
TFThierry Fest
Thierry Fest
The differentiation of B cells into plasmablasts (PBs) and then plasma cells (PCs) is associated with extensive cell reprogramming and new cell functions. By using specific inhibition strategies (including a novel morpholino RNA antisense approach), we found that early, sustained upregulation of the proviral integrations of Moloney virus 2 (PIM2) kinase is a pivotal event during human B-cell in vitro differentiation and then continues in mature normal and malignant PCs in the bone marrow. In particular, PIM2 sustained the G1/S transition by acting on CDC25A and p27Kip1 and hindering caspase 3–driven apoptosis through BAD phosphorylation and cytoplasmic stabilization of p21Cip1. In PCs, interleukin-6 triggered PIM2 expression, resulting in antiapoptotic effects on which malignant PCs were particularly dependent. In multiple myeloma, pan-PIM and myeloid cell leukemia-1 (MCL1) inhibitors displayed synergistic activity. Our results highlight a cell-autonomous function that links kinase activity to the newly acquired secretion ability of the PBs and the adaptability observed in both normal and malignant PCs. These findings should finally prompt the reconsideration of PIM2 as a therapeutic target in multiple myeloma.

16 March 2022 in Scandinavian Journal of Immunology
Verified
Journal Article
Open access
AMAnne Marchalot
Anne Marchalot
JMJenny Mjösberg
Jenny Mjösberg
Innate lymphoid cells (ILC) can be viewed as the innate counterparts of T cells. In contrast to T cells, ILCs exert their functions in antigen‐independent manners, relying on tissue‐derived signals from other immune cells, stroma and neurons. Natural killer (NK) cells have been known for their antitumour effects for decades. However, the roles of other ILC subtypes in cancer immunity are just now starting to be unravelled. ILCs contribute to both homeostasis and inflammation in the intestinal mucosa. Intestinal inflammation predisposes the intestine for the development of colonic dysplasia and colorectal cancer (CRC). Recent data from mouse models and human studies indicate that ILCs play a role in CRC, exerting both protumoural and antitumoural functions. Studies also suggest that intratumoural ILC frequencies and expression of ILC signature genes can predict disease progression and response to PD‐1 checkpoint therapy in CRC. In this mini‐review, we focus on such recent insights and their implications for understanding the immunobiology of CRC. We also identify knowledge gaps and research areas that require further work.

18 July 2025 in Science Immunology
Verified
Journal Article
Closed access
JNJulia Niessl
Julia Niessl
TMThomas R. Müller
Thomas R. Müller
CCChristian Constantz
Christian Constantz
CCCurtis Cai
Curtis Cai
VNVera Nilsén
Vera Nilsén
MBMarcus Buggert
Marcus Buggert
CD8 + T cells are classically defined by cytotoxic activity, but it has remained unclear whether cytotoxic programs are compartmentalized across tissues and memory subsets. Here, we established a human organ donor cohort and found that expression of conventional cytotoxic molecules—granulysin, perforin, and granzyme B—was most prominent among circulating memory CD8 + T cells and decreased progressively with tissue residency, inversely mirroring the expression of CD69 and CD103. Other cytotoxic molecules, including granzymes A, H, K, and M, were variably expressed across tissues, and memory CD8 + T cells targeting persistent viruses expressed multiple granzymes coordinately. In an in vitro tonsil system, transforming growth factor–β induced discordant regulation of cytotoxic molecules and CD103. Combined with interleukin-15, this circuitry modulated proliferation and the acquisition of redirected killing activity via perforin and granzyme B. Our findings suggest that human memory CD8 + T cell cytotoxicity is intricately regulated by environmental cues reflecting tissue location and antigen specificity.

9 January 2026 in Science Advances
Verified
Journal Article
Open access
OBOlga Rivera Ballesteros
Olga Rivera Ballesteros
LRLisa Rieble
Lisa Rieble
CCCurtis Cai
Curtis Cai
TSTakuya Sekine
Takuya Sekine
VNVera Nilsén
Vera Nilsén
MBMarcus Buggert
Marcus Buggert
CXCR5 + CD8 + T cells emerged as key mediators of antiviral immunity in the context of chronic infection. However, their functional attributes and tissue distribution remain incompletely defined, especially in relation to antigen specificity. Here, we investigated the anatomical localization and antiviral properties of CXCR5 + CD8 + T cells across multiple sites throughout the human body, with an emphasis on oropharyngeal lymphoid tissues. Tonsils harbored the highest frequencies of CXCR5 + CD8 + T cells compared to other tissues, many of which expressed Granzyme K and concurrently displayed tissue residency features, as demonstrated by single cell profiling. Irrespective of clonal identity and virus specificity, CD8 + T cells expressed CXCR5 more commonly in tonsils compared to vascular circulation. CXCR5 expression was particularly prominent among tonsil-localized CD8 + T cells targeting Epstein-Barr virus (EBV) latent antigens and associated with a PD-1 + resident stem-like phenotype. These data identify a CXCR5 + tissue-resident memory CD8 + T cell subset in human tonsils with a potential role in immune surveillance of EBV.

27 March 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
AMAnne Marchalot
Anne Marchalot
MLMalin Ljunggren
Malin Ljunggren
CSChristopher Stamper
Christopher Stamper
WWWhitney Weigel
Whitney Weigel
CTChristopher Andrew Tibbitt
Christopher Andrew Tibbitt
JMJenny Mjösberg
Jenny Mjösberg
Peritoneal metastases (PM) occur in 10% of patients with colorectal cancer (CRC) and are linked to poor outcomes. Although dysregulated innate lymphoid cells (ILC) have been described in CRC, their function in CRC-PM remains unclear. Here, we analyze tumor samples from CRC and CRC-PM patients using single-cell RNA sequencing (11 patients), flow cytometry (8 patients) and differentiation assays (24 patients). Healthy colon, primary CRC and CRC-PM tumors are infiltrated by heterogeneous populations of ILC3, ILC2, ILC1, tissue resident (tr)NK cells and conventional (c)NK cells. Compared to healthy colons, primary CRC and CRC-PM tumors are depleted of ILC3 but enriched for ILC1, trNK cells and cNK cells. CRC and CRC-PM tumors harbor two immature ILC populations, early NK and naïve (n)ILC, with nILCs being transcriptionally skewed toward ILC1 and trNK cells. Indeed, co-culture of isolated nILCs with OP9-DL1 cells induces intratumoral nILC differentiation into ILC1/trNK-like cells. These findings help understand the immune pathogenesis of CRC and CRC-PM and provide insights for future ILC1 and NK cell-based therapies.

15 May 2026 in Science Advances
Verified
Journal Article
Open access
TKTobias Kammann
Tobias Kammann
IVIsabel Voigt
Isabel Voigt
NWNicole Wild
Nicole Wild
EKEfthymia Kokkinou
Efthymia Kokkinou
CCCurtis Cai
Curtis Cai
JSJohan Sandberg
Johan Sandberg
The human tissue–resident T cell pool consists of a diverse array of conventional adaptive as well as unconventional invariant T cells that populate barrier sites and carefully balance immune defense in the context of microbial exposure. Here, we investigated the tissue-resident CD4 T cell compartment across donor-matched lymphoid and nonlymphoid tissues and uncovered a population enriched primarily in the ileum and liver displaying a rich polyfunctional profile with diverse T helper 1/17/22 characteristics. These CD4 T cells were highly responsive, susceptible to innate cytokine–driven activation, and identified by CD161 and CD56 coexpression. Their transcriptional and protein expression profile included innate-like effector features including NKp80, NKG2D, NKG7, as well as granzyme K, and exhibited characteristics of tissue residence, persistence, and barrier repair, and they were depleted in the colon of patients with inflammatory bowel disease. Notably, the CD161 + CD56 + CD4 T cell pool was expanded in cytomegalovirus (CMV)–seropositive individuals and enriched in CMV-specific T cell receptors and responses. Together, we identify a potent effector-memory CD4 T cell subset resident in the gastrointestinal tract and liver, defined by enhanced innateness and enriched in CMV-specificity.